AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2640-1045/043
1 Undergraduate Student of Medicine at UnP - Potiguar University – Laureate International Universities – Natal/Brazil.
2 Urologist and Professor at Potiguar University / UnP - Laureate International Universities – Natal/Brazil.
3 Postgraduate Program in Biotechnology at Potiguar University/ UnP - Laureate International Universities – Natal/Brazil. Ph.D. in Health Science.
4 Full Professor Department of Surgery, Federal University of Rio Grande do Norte. Postgraduate Program in Biotechnology at Potiguar University/ UnP - Laureate International Universities – Natal/Brazil. Ph.D. in Health Science.
*Corresponding Author: Irami Araújo-Filho, Full Professor Department of Surgery, Federal University of Rio Grande do Norte. Postgraduate Program in Biotechnology at Potiguar University/ UnP - Laureate International Universities – Natal/Brazil. Ph.D. in Health Science.
Citation: Rebecca RLM., Karina AV., Arnaldo SN., Amália CMR and Irami AF. Tamsulosin and Dementia in Old Age: is There Any Relationship?. J Endocrinology and Disorders. 3(1): Doi:10.31579/2640-1045/043
Copyright: © 2019 Irami AF. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 17 September 2019 | Accepted: 11 October 2019 | Published: 19 October 2019
Keywords: benign prostatic hyperplasia; prostatic hyperplasia; cognitive functions; tamsulosin; dementia; adrenergic alpha-1 receptor antagonists
Tamsulosin is used to treat Benign Prostatic Hyperplasia (BPH), prescribed annually to about 12.6 million patients worldwide. It is an alpha-adrenergic antagonist that reduces the tone of the prostate smooth muscle involved in the pathophysiology of BPH. By acting on alpha 1A receptors, predominant in the prostate, tamsulosin also acts on receptors present in the brain. This study consisted of a literature review aimed at disseminating scientific knowledge about the relationship between the use of tamsulosin and the onset of dementia. Pubmed, Scopus, Scielo, Embase, and Web of Science studies involving dementia in patients using tamsulosin in the last five years were selected. The review showed a risk correlation and a higher incidence of dementia in treated patients. The risk ratio, when compared to other medicines, approached 1.20. In conclusion, it was identified the need for clinical trials with higher sampling power to increase relational significance due to the high prevalence of BPH and the extensive use of tamsulosin in elderly patients with the disease.
Benign prostatic hyperplasia (BPH) is a common disease among older men and responsible for several physiological disorders. The healthy prostate weighs approximately 20g, however, due to the increasing number of individuals with BPH, the average prostate weight at autopsy increases from the age of 50, reaching twice or triple the weight in some cases1. Risk factors associated with BPH are black race, family history of bladder cancer, and prostatitis. Protective factors refer to elevated serum estradiol, testosterone, and anti-inflammatory levels [1]. This condition may be clinically asymptomatic, but 50% of men aged ≥ 50 years and 80% of those ≥ 80 years have increased urinary frequency, nocturia, urinary urgency, incontinence, hesitation, intermittent flow, bladder emptying effort, slow flow, or the division of urinary flow [2]. Depending on the symptoms and severity of the disease, pharmacological treatment with alpha-adrenergic blockers is indicated, balancing aspects of symptomatic severity and potential side effects of the drug used [2]. Widely widespread, tamsulosin is only instituted in cases in which the patient's quality of life is compromised. Besides, there are many cases of stabilization and attenuation of symptoms, even without therapeutic intervention [2,3]. Tamsulosin has effective selective action, blocks alpha-1A adrenergic receptors and causes mild adverse effects, including orthostatic hypotension. It is an easy-to-use medicine that promotes rapid symptomatic improvement and is, therefore, suitable for older patients [3]. Although it has several benefits, its effects in the medium and long term should be considered. Thus, a drug-epidemiological study has pointedly demonstrated the relationship between tamsulosin and the high risk of dementia in this group of patients. One hypothesis is that tamsulosin acts on prostate and brain alpha receptors, thus stimulating cognitive dysfunction, a precursor of dementia[3]. Based on this principle, studies that contribute to elucidate this association brings significant implications of high scientific value for the health of the world population that is undergoing a full aging process. Due to the importance of the theme, the present review aimed to evaluate scientifically validated evidence on the use of tamsulosin and its association with the onset of dementia in patients with benign prostatic hyperplasia (BPH) [4].
Methods
A search was performed in the Pubmed, Scopus, Scielo, Embase, and Web of Science databases, as well as Google Scholar search, considered as gray literature. We selected articles related to the use of tamsulosin and dementia over the past five years and were chosen by combining the following keywords: benign prostatic hyperplasia, prostatic hyperplasia, cognitive functions, tamsulosin, dementia, adrenergic alpha-1 receptor antagonists. There included cohort studies, systematic review, case-control, cross-sectional, case series studies, and randomized controlled trials. The inclusion criteria adopted were human studies, complete articles, of high scientific value, and published in the last five years. The analysis, review, and selection of articles was made by pairs, separately, from the reading of the title and summary of each study, with a third reviewer in case of disagreement between the other two reviewers.
Benign Prostatic Hyperplasia and Dementia
Benign prostatic hyperplasia (BPH) is defined as the presence of hyperplastic glands during a pathological analysis of prostate tissue. Approximately 60% of patients have symptoms of moderate to severe BPH. However, new cases at an early stage are detected due to new screening methods [5]. Two mechanisms cause urinary symptoms: excessive growth of prostate tissue that causes obstructions to urinary flow and enlarged prostate smooth muscle cells, resulting in increased resistance to urinary flow [5,6].
Another relevant and current theme concerning the elderly is the increase in the average life expectancy and the high prevalence of Alzheimer's disease and dementia in this age group. These diseases are costly, as are heart disease and cancer, yet effective drug alternatives are scarce [6]. For this reason, it is necessary to understand the pathogenesis of dementia and possible avoidable etiological causes.
Association of Dementia and Tamsulosin
Duan et al. conducted the first study on the association between Tamsulosin use and the development of dementia in elderly patients with BPH [6]. It was a retrospective cohort study that looked at US Medicare beneficiaries older than 66 years and diagnosed with BPH within six years [7]. Related groups with the same eligibility criteria were used: the first including patients with BPH who did not use any medication, the second by patients using other α1-adrenoreceptor antagonists (doxazosin, terazosin or alfuzosin) and the third group involving patients using 5α-reductase inhibitors, i.e., dutasteride, and finasteride [6-8]. All patients were followed for the following outcomes: dementia, exclusion (death, initiation of a different HPB medication, or loss of Medicare coverage) and study termination [7]. The final study sample included: HPB/tamsulosin group (n = 253,136); HPB (n = 180,926); HPB/doxazosin (n = 28,581); HPB/terazosin (n = 23,858); HPB/alfuzosin (n = 17,934); HPB/dutasteride (n = 34,027); and HPB/finasteride (n = 38,767). The average follow-up period was 19.8 months [7]. According to Duan et al., tamsulosin did not show greater efficacy and tolerability than other common α1 receptor antagonists, despite having greater selectivity [3]. As a result, it was observed that the tamsulosin group had a higher gross incidence of dementia, being 38.8/1000 patients/year compared with 24.1-32.8 / 1000 patients/year in the other comparative groups [8]. In addition, these patients scored higher on the Charlson Comorbidity Index and were more likely to have cerebrovascular disease, peripheral vascular disease, congestive heart failure, myocardial infarction, delirium, traumatic brain injury, Parkinson's disease, and depression; requiring greater assistance from health services [7]. Compared to patients without treatment for BPH, the tamsulosin group showed a significantly increased risk of dementia 31.3 versus 25.9 / 1000 person/year. With this in mind, tamsulosin use was significantly associated with an increased risk of dementia when compared with each of the five groups of patients who used alternative medicines for BPH [7]. This first study by Duan et al. is considered in the literature as the teste α and has emerged to determine if there are insights to consider between tamsulosin and dementia. Other criteria, such as β, have been proposed by Gill et al., who found the number needed to harm (NNP) between drug users and an individual develop the deficit of 186, so the relationship between developing dementia is relatively small if there is any relationship [6]. Despite poor blood-brain barrier penetration, there is a high affinity for all neurotransmitter receptors (α1-adrenergic, dopaminergic, and serotonergic) that regulate and modulate essential central nervous system functions such as mood, affect, attention, learning, and memory [9]. Accordingly, a study in humans has shown that there is a reduction in alpha-adrenergic receptors in the prefrontal cortex of elderly patients with associated dementia [4]. One factor that refutes this higher likelihood of associated risk in patients using tamsulosin is the persistence of higher propensity in dose-dependent cases. However, those at higher risk are unlikely to have received more [7]. According to Frankel, this dementia change may be a consequence of the masking of the initial symptoms, which would already be present in the course of the disease. However, if this were true, it would not be possible to evidence moderate and severe cases, as documented in the same study, and there would be no dose-dependence [4].
Tamsulosin/Dose Response Ratio
Dementia Risk
The risks of dementia associated with the tamsulosin, doxazosin, terazosin, and dutasteride groups were not different from the reference levels found previously or when used at low doses [7]. However, the use of tamsulosin considerably increased the risk of dementia associated with medium and high doses, which was also observed with alfuzosin and finasteride. Moreover, age or race did not change; in proportion, the association between tamsulosin use and risk of dementia in almost all analyzes [7,8].
Dementia and Tamsulosin
Opposing Factors
According to Ulrich, the prescription of tamsulosin occurs in large proportions for HPB due to the simplicity of its use. Unlike other alpha-blockers, only one daily dose is required with fewer adverse effects related to orthostatic hypotension and rapid symptom improvement, reasonable efficacy, and price [3, 4]. Importantly, the common side effects of all drugs evaluated are vasodilation, dizziness, flaccid iris syndrome, runny nose. In particular, tamsulosin may delay ejaculation in 38% of cases [4,8].
Another confounding factor is that tamsulosin has reduced passage in the blood-brain barrier, and it is not known how dementia can be caused even with this minimal penetration [7]. Ulrich described that this association is uncertain, because the prescription of this drug may be performed in patients who already have Mild Cognitive Impairment (MCI), which is a predictor of dementia, even if still controversial since studies are conducted a form of a retrospective analysis of medical records [3]. Another different factor is regarding the onset of dementia due to the alpha-receptor blockade. Therapeutic doses of tamsulosin, as well as drugs of the same class, could cause inhibition of adrenoreceptors. However, as evidenced by Duan et al., tamsulosin has a powerful effect [7]. According to Madersbacher and Michel, Duan's study has limitations regarding the relationship between tamsulosin use and cognitive dysfunction due to the average observation time adopted, considered relatively short (19.8 months) for a chronic pathology [7,8]. Another point concerns the probable selection bias since the sample selected by Duan had a higher risk of dementia at the time of tamsulosin prescription since they were elderly patients [7-9]. Kolisov et al. conducted a study by administering high doses of solifenacin®, an antimuscarinic, simultaneously to tamsulosin. There were no sequelae in the cognitive abilities of patients with BPH and symptoms of overactive bladder, and there was even an improvement in the quality of life in the experimental group [9,10]. In this case, the administration of higher doses of tamsulosin-associated solifenacin was effective and safe in treating BPH [8].
An alternative to quantifying and complementing the study related to the use of tamsulosin and penetration into the central nervous system causing dementia is to structure research that quantifies the Quantitative-Structure-Property Relationship (RQEP) by chromatography. RQEP models have already been tested in the use of imidazoline ligands and adrenergic receptors, with scientifically validated significance and efficiency [11].
Conclusion
In conclusion, tamsulosin is effective in treating BPH, as well as having satisfactory cost-effectiveness. However, some hypotheses need to be proven, as cognitive dysfunction may be an immediate adverse effect. Such phenomenon requires caution due to the affinity of tamsulosin with alpha-adrenergic receptors and the genesis of progressive cortical dementia.
However, although cases of the association between its use and the development of dementia are described, a more in-depth study on this relationship is necessary, as other factors may be responsible for tamsulosin. As described in the discussion, some patients already had MCI which may predict increased risk for dementia, in addition to their characteristics of tamsulosin, for example, the fact that it does not cross the blood-brain barrier easily. More effort is needed in randomized experimental studies testing tamsulosin in vitro and in vivo to assess its neurotoxicity and bioavailability, especially in the central nervous system. Besides, brain biopsy studies are needed to analyze pathological changes caused by its use compared to other alpha-adrenergic antagonists and control groups.
Compliance with ethical standards
Acknowledgments
The authors thank Prof. Dr. Aldo Medeiros, Full Professor of the Department of Surgery - UFRN, for the supervision of this review, acting as an expert consultant on the bibliographic survey, analysis, and scientific advice. We also thank all the study components for their dedication and effort to build a scientifically validated quality review.
Disclosure of conflict of interest
There are no conflicts of interest to declare by any of the authors of this study.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
